What we do
Claris Ventures makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.
We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas.
We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence.
Team
Portfolio
Do you want to...
Propose your idea?
Join a young and high challenging environment?
Our Office
Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.
Claris Biotech I is also supported by AlpGIP (the first multi-regional investment fund of the Alpine macro-region established by the EIF) and by the Pan-European Guarantee Fund (fund managed by the European Investment Bank Group aimed at ensuring that companies in EU member states have sufficient short-term liquidity to overcome crisis and to continue their growth and development in the medium to long term).